Tingting Yang

Tingting Yang

Auto-generated profile, based on publicly available information

Tingting Yang

College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin, People’s Republic of China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2021 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
LZLi-Ying Zhang
Li-Ying Zhang
JYJia-Ying Yu
Jia-Ying Yu
YLYan-Long Leng
Yan-Long Leng
RZRan-Ran Zhu
Ran-Ran Zhu
HLHong-Xian Liu
Hong-Xian Liu
XZXinchen Zhang
Xinchen Zhang

19 January 2022 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Closed access
PDF file
QZQifeng Zheng
Qifeng Zheng
QLQianqian Li
Qianqian Li
TYTingting Yang
Tingting Yang
WQWuqin Qi
Wuqin Qi
YZYanqing Zhang
Yanqing Zhang
JXJunbo Xie
Junbo Xie

20 June 2018
Verified
Journal Article
Open access
PDF file
TYTingting Yang
Tingting Yang
JGJingjing Gu
Jingjing Gu
TLTing Liu
Ting Liu
HMHaibin Ma
Haibin Ma
XMXiaona Ma
Xiaona Ma
XLXueyun Liang
Xueyun Liang
Background and objective Tumor recurrence and drug resistance are the main causes of death in tumor patients. The family of acetaldehyde dehydrogenase (ALDH) is closely related to the proliferation, migration, invasion and resistance of tumor cells, and different ALDH subtypes are expressed in different tumor cells. The aim of this study is to elucidate the ALDH subtype in human lung adenocarcinoma HCC-827/GR cells, which resistant to the gefitinib. Methods The human lung adenocarcinoma HCC-827 cells were used to generate the gefitinib-resistant HCC-827/GR cells; the expression of ALDH subtype in either HCC-827 or HCC-827/GR was detected by flow cytometry; The proliferative capacity and sensitivity to gefitinib of hcc-827/GR cells were analyzed by MTT assay before and after treatment with 100 μmol/L diethyllaminaldehyde (DEAB); Real-time quantitative PCR was used to detect the expression of ALDH subtypes at mRNA levels in hcc-827 cells and hcc-827/GR cells. Results Compared with HCC-827 cells, the positive rate of ALDH in HCC-827/GR cells increased. The proliferation ability of HCC-827/GR cells decreased after treatment with 100 μmol/L DEAB. Compared with HCC-827 cells, the expression of ALDH1A1 and ALDH1L1 mRNA was increased in hcc-827/GR cells, but the ALDH3B2 expression was decreased. Conclusion ALDH might be used as a molecular biomarker to test the gefitinib-resistant to lung adenocarcinoma cancer cells, and the ALDH1A1 may play a role in gefitinib resistance in lung cancer. DOI: 10.3779/j.issn.1009-3419.2018.06.01

1 October 2020 in Journal of Biomedical Nanotechnology
Verified
Journal Article
Closed access
TYTingting Yang
Tingting Yang
TLTing Luo
Ting Luo
HGHongjun Guo
Hongjun Guo
YHYuzhu Hu
Yuzhu Hu
YLYunzhu Lin
Yunzhu Lin
BWBilan Wang
Bilan Wang
Gene therapy has been widely studied in colon cancer treatment. However, effective delivery of genes is a limitation for clinical applications. In the research, DOATP/mPEG-PLA-mPEG (DPLP) nanoparticles carrying the vesicular stomatitis virus matrix protein plasmid (pVSVMP) was used for colon cancer therapy, resulting in high transfection efficiency and expression efficiency in CT26 cells. Moreover, the DPLP-pVSVMP complex was provide with apoptosis induction and proliferation suppression of CT26 cells in vitro and can efficiently inhibit tumor growth in murine colon cancer model by inducing apoptosis, suppressing proliferation and angiogenesis. These results suggest that DPLP nanoparticles delivering pVSVMP might be a latent therapeutic avenue for colon cancer.